Article info

Download PDFPDF

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
  1. Correspondence to:
    Dr J Askling
    Clinical Epidemiology Unit M9:01, Karolinska University Hospital Solna, SE-171 76 Stockholm, Sweden; johan.asklingmedks.ki.se
View Full Text

Citation

Askling J, Fored CM, Baecklund E, et al
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists

Publication history

  • Accepted April 6, 2005
  • First published April 20, 2005.
Online issue publication 
September 14, 2005

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.